Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents

Clinical Biochemistry

Volumn 45, Issue 1-2, 2012, Pages 16-21

  Hyun, Sei Eun ^a   Lee, Byung Churl ^b   Suh, Byung Kyu ^b   Chung, So Chung ^c   Ko, Cheol Woo ^d   Kim, Heung Sik ^e   Lee, Kee Hyoung ^f   Yang, Sei Won ^g   Shin, Choong Ho ^g   Hwang, Jin Soon ^h   Kim, Duk Hee ^a   Lim, Baek Keun ⁱ   Kim, Jong Duck ^j   Yoo, Han Wook ^k   Kim, Hye Soon ^l   Chung, Woo Yeong ^m   Park, Mi Jung ^m   Woo, Young Jong ⁿ   Kim, Chan Jong ⁿ   Lee, Dae Yeol ^o   Kim, Eun Young ^p   Choi, Jin Ho ^q   Han, Heon Seok ^r   Hwang, Il Tae ^s   Kim, Ho Seong ^a   more..

^a Yonsei University College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Konkuk University   (South Korea)

^d Kyungpook National University   (South Korea)

^e Keimyung University   (South Korea)

^f Korea University   (South Korea)

^g Seoul National University   (South Korea)

^h Ajou University   (South Korea)

ⁱ Yonsei University Wonju College of Medicine   (South Korea)

^j Wonkang University   (South Korea)

^k University of Ulsan   (South Korea)

^l Ewha Womans University   (South Korea)

^m Inje University   (South Korea)

ⁿ Chonnam National University   (South Korea)

^o Chonbuk National University   (South Korea)

^p Chosun University   (South Korea)

^q Chungnam National University   (South Korea)

^r Chungbuk National University   (South Korea)

^s Hallym University   (South Korea)

more..

Author keywords

Adolescent; Child; IGF I; IGFBP 3; Korean

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; AGE; ARTICLE; ASIAN; BLOOD ANALYSIS; BODY MASS; BODY WEIGHT; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBERTY; REFERENCE VALUE; SCHOOL CHILD; SEROLOGY; SEX DIFFERENCE; SOMATOMEDIN BINDING PROTEIN 3 BLOOD LEVEL; SOMATOMEDIN C BLOOD LEVEL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH DISORDERS; HUMANS; IMMUNORADIOMETRIC ASSAY; INFANT; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; KOREA; MALE; REFERENCE VALUES;

EID: 84855326988     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.10.003     Document Type: Article

References (31)

1. Daughaday W.H., Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr Rev 1989, 10:68-91.
2. Baxter R.C., Martin J.L. Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res 1989, 1:49-68.
3. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995, 16:3-34.
4. Le Roith D., Bondy C., Yakar S., Liu J.L., Butler A. The somatomedin hypothesis: 2001. Endocr Rev 2001, 22:53-74.
5. Oh Y., Muller H.L., Lamson G., Rosenfeld R.G. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem 1993, 268:14964-14971.
6. Kim H.S., Rosenfeld R.G., Oh Y. Biological roles of insulin-like growth factor binding proteins (IGFBPs). Exp Mol Med 1997, 29:85-96.
7. Rosenfeld R.G., Wilson D.M., Lee P.D.K., Hintz R.L. Insulin-like growth factors I and II in the evaluation of growth retardation. J Pediatr 1986, 109:428-433.
8. Rosenfeld R.G., Cohen P. Disorders of growth hormone/insulin-like growth factor secretion and action. Pediatric Endocrinology 2008, 254-334. Saunders, Philadelphia, Pennsylvania. 3rd ed.
9. Zapf J., Walter H., Froesch E.R. Radioimmunological determination of insulin like growth factor I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest 1981, 68:1321-1330.
10. Ranke M.B., Schweizer R., Elmlinger M.W., Weber K., Binder G., Schwarze C.P., et al. Significance of basal IGF-I, IGFBP-3 and IGFBP-2 measurements in the diagnostics of short stature in children. Horm Res 2000, 54:60-68.
11. Blum W.F., Ranke M.B., Kietzmann K., Gauggel E., Zeisel H.J., Bierich J.R. A specific radioimmunoassay for the growth hormone-dependent somatomedin-binding protein: its use for diagnosis for GH deficiency. J Clin Endocrinol Metab 1990, 70:1292-1298.
12. Kristrom B., Jansson C., Rosberg S., Albertsson-Wikland K. Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. Swedish Study Group for Growth Hormone Treatment. J Clin Endocrinol Metab 1997, 82:2889-2898.
13. Wikland K.A., Kristrom B., Rosberg S., Svensson B., Nierop A.F. Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities. Pediatr Res 2000, 48:475-484.
14. Bussieres L., Souberbielle J.C., Pinto G., Adan L., Noel M., Brauner R. The use of insulin-like growth factor 1 reference values for the diagnosis of growth hormone deficiency in prepubertal children. Clin Endocrinol (Oxf) 2000, 52:735-739.
15. Tillmann V., Buckler J.M., Kibirige M.S., Price D.A., Shalet S.M., Wales J.K., et al. Biochemical tests in the diagnosis of childhood growth hormone deficiency. J Clin Endocrinol Metab 1997, 82:531-535.
16. Clemmons D.R., Klibanski A., Underwood L.E., McArthur J.W., Ridgway E.C., Beitins I.Z., et al. Reduction of plasma immunoreactive somatomedin C during fasting in humans. J Clin Endocrinol Metab 1981, 53:1247-1250.
17. Ranke M.B., Feldt-Rasmussen U., Bang P., Baxter R.C., Camacho-Hubner C., Clemmons D.R., et al. How should insulin-like growth factor I be measured? A consensus statement. Horm Res 2001, 55:106-109.
18. Korea Center for Disease Control and Prevention, The Korean Pediatric Society, The Committee for the Development of Growth Standard for Korean Children and Adolescents. 2007 Korean children and adolescents growth standard (commentary for the development of 2007 growth chart). [Government report online]. Seoul: Division of Chronic Disease Surveillance; 2007 Nov. Available from: URL;//. http://www.cdc.go.kr/.andURL;//http://www.pediatrics.or.kr/.
19. Argente J., Barrios V., Pozo J., Munoz M.T., Hervas F., Stene M., et al. Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age- and sex-related changes. J Clin Endocrinol Metab 1993, 77:1522-1528.
20. Lofqvist C., Andersson E., Gelander L., Rosberg S., Blum W.F., Albertsson Wikland K. Reference values for IGF-I throughout childhood and adolescence: a model that accounts simultaneously for the effect of gender, age, and puberty. J Clin Endocrinol Metab 2001, 86:5870-5876.
21. Elmlinger M.W., Kuhnel W., Weber M.M., Ranke M.B. Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin Chem Lab Med 2004, 42:654-664.
22. Lofqvist C., Andersson E., Gelander L., Rosberg S., Hulthen L., Blum W.F., et al. Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence. J Clin Endocrinol Metab 2005, 90:1420-1427.
23. Bereket A., Turan S., Omar A., Berber M., Ozen A., Akbenlioglu C., et al. Serum IGF-I and IGFBP-3 levels of Turkish children during childhood and adolescence: establishment of reference ranges with emphasis on puberty. Horm Res 2006, 65:96-105.
24. Kong A.P., Wong G.W., Choi K.C., Ho C.S., Chan M.H., Lam C.W., et al. Reference values for serum levels of insulin-like growth factor (IGF-1) and IGF-binding protein 3 (IGFBP-3) and their ratio in Chinese adolescents. Clin Biochem 2007, 40:1093-1099.
25. Xu S., Gu X., Pan H., Zhu H., Gong F., Li Y., et al. Reference ranges for serum IGF-1 and IGFBP-3 levels in Chinese children during childhood and adolescence. Endocr J 2010, 57:221-228.
26. Juul A., Dalgaard P., Blum W.F., Bang P., Hall K., Michaelsen K.F., et al. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995, 80:2534-2542.
27. Juul A., Bang P., Hertel N.T., Main K., Dalgaard P., Jorgensen K., et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994, 78:744-752.
28. Cara J.F., Rosenfield R.L., Furlanetto R.W. A longitudinal study of the relationship of plasma somatomedin-C concentration to the pubertal growth spurt. Am J Dis Child 1987, 141:562-564.
29. Casazza K., Higgins P.B., Fernandez J.R., Goran M.I., Gower B.A. Longitudinal analysis of the insulin-like growth factor system in African-American and European American children and adolescents. J Clin Endocrinol Metab 2008, 93:4917-4923.
30. Blum W.F., Albertsson-Wikland K., Rosberg S., Ranke M.B. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 1993, 76:1610-1616.
31. Ho K.K., O'Sullivan A.J., Weissberger A.J., Kelly J.J. Sex steroid regulation of growth hormone secretion and action. Horm Res 1996, 45:67-73.